Hellman & Friedman (H&F) is one of the most experienced private equity investment firms, focused on making large-scale equity investments in outstanding, market-leading growth businesses. The firm invests across technology, healthcare, financial services, consumer, and information services sectors.
33% of their portfolio is in Healthcare. They made 1 investment in the last 12 months. Average disclosed round size is $261.6M (across 11 rounds with reported amounts).
Portfolio
12
Fund Size
$22.3B
Top Stage
Unknown
Last 12 Mo
1
Team
SO
Sean O'Brien
Managing Director
TA
Ted Akiskalos
Managing Director
BF
Benjamin Farkas
Partner
BD
Brian Doyle
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Unknown | — | Oct 2025 | |
| Series B | $30M | May 2024 | |
| Growth | $90M | Dec 2023 | |
| Series B | $30M | Feb 2023 | |
| Unknown | — | Jun 2021 | |
| EEdelman Financial | Growth | $1B | Jan 2021 |
| Series A | $40M | Dec 2020 | |
| Growth | $200M | Sep 2020 | |
| Unknown | $600M | Jan 2019 | |
| PPharmaceutical Product Development, LLC | Unknown | $550M | Apr 2017 |
| Unknown | $200M | Jan 2009 | |
| Unknown | $113M | Mar 2000 | |
| Seed | $25M | — | |
| Unknown | — | — | |
| Unknown | — | — |
Top Co-Investors
GIC Private Limited3 shared
The Carlyle Group3 shared
General Catalyst2 shared
Hamilton Lane2 shared
Clearlake Capital Group2 shared
The Vistria Group2 shared
S&P Global2 shared
Battery Ventures1 shared
KKR1 shared
Scale Venture Partners1 shared
Y Combinator1 shared
Bain Capital Life Sciences1 shared
Blackstone Inc.1 shared
MMC Ventures1 shared
Motive Partners1 shared
CVC Capital Partners1 shared
Flexpoint Ford1 shared
Warburg Pincus LLC1 shared
Abu Dhabi Investment Authority1 shared
Last updated: 20 October 2026
